Healthcare and consumer wellness leader brings extensive experience in business transformation, commercial strategy and growth leadership to Fertin India
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
The company’s Growth Portfolio delivered $6.2 billion in revenue
The company posted revenue of €1,267 million, up 6% on a constant currency basis
But acquisition charges drag earnings into loss
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Subscribe To Our Newsletter & Stay Updated
